| Family: | Invesco |
| Name: | Invesco Pharmaceuticals ETF |
| Inception Date: | 23-Jun-2005 |
| Termination Date: | |
| Investment Objective: | The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November. |
| Prospectus | |
| Top 10 Holdings | ||
| GILEAD SCIENCES INC USD 0.001 | GILD | 5.8502% |
| MERCK + CO INC NEW USD 0.5 | MRK | 5.8338% |
| JOHNSON + JOHNSON USD 1.0 | JNJ | 5.5938% |
| AMGEN INC USD 0.0001 | AMGN | 5.5255% |
| PFIZER INC USD 0.05 | PFE | 5.1857% |
| LILLY ELI + CO NPV | LLY | 4.7589% |
| ABBVIE INC USD 0.01 | ABBV | 4.6766% |
| ABBOTT LABS NPV | ABT | 4.1863% |
| LIQUIDIA CORPORATION USD 0.001 | LQDA | 3.8344% |
| VIATRIS INC NPV | VTRS | 3.6705% |
| Top 10 Holdings Weight: | 49.1% |
| Number of Holdings: | 32 |
| Shares Outstanding: | 3,770,000 |
| Total Net Assets: | 412,698,100 |
| NAV: | 109.54 |
| Net Expense Ratio: | 0.57% |
| Asset Class: | Equities (Stocks) |
| Developed or Emerging: | Developed Market Funds |
| Country: | US |
| Region: | |
| Strategy: | NYSE Intellidex proprietary model |
| Currency: | |
| Commodity: | |
| Sector: | Healthcare |
| Industry: | Pharmaceuticals |
| Dividend Type: | |
| Tax Exempt State: | |
| Maturity Duration: | |
| Market Cap: | Broad Market / Multi-Cap |
| Credit Quality: | |
| Mortgage Bond Types: | |
| Bond Type: | |
| Gov't Bond Types: | |
| Reit Type: | |
| Leverage Direction/Factor: | |
| Is Currency Hedged: | No |
| US or Ex-US: | Domestic |
